Treatment of Confirmed Syphilis Infection

Diagnostic Interpretation

Direct detection of Treponema pallidum by darkfield examination or direct fluorescent antibody testing is the gold standard for diagnosing early syphilis and confirms active infection, as recommended by the Centers for Disease Control and Prevention 1, 2, 3.
A low RPR titer of 1:1, when combined with direct organism visualization, represents confirmed active syphilis infection, according to the Centers for Disease Control and Prevention 1, 2.
Nontreponemal tests (RPR/VDRL) typically correlate with disease activity, but low titers can occur in early primary syphilis or in patients with very recent infection, as noted by the Centers for Disease Control and Prevention 1, 3.

The Centers for Disease Control and Prevention recommends administering benzathine penicillin G 2.4 million units intramuscularly as a single dose for presumed primary or early syphilis 3, 5.
For patients who have had symptoms or known exposure for more than one year, or if the duration is unknown, the Centers for Disease Control and Prevention recommends treating as late latent syphilis with benzathine penicillin G 2.4 million units IM weekly for three consecutive weeks (total 7.2 million units) 3, 5.

The Centers for Disease Control and Prevention recommends evaluating for neurosyphilis, ocular syphilis, or otic syphilis by assessing for neurologic symptoms, visual changes, or hearing loss, as these require IV penicillin therapy instead 6.
Obtaining a detailed sexual history to determine timing of exposure and stage of infection is recommended by the Centers for Disease Control and Prevention 1, 3.
The Centers for Disease Control and Prevention recommends screening for HIV infection, as HIV-positive patients may have atypical presentations and require closer monitoring 2, 3, 5.

The Centers for Disease Control and Prevention recommends repeating quantitative RPR testing at 6 and 12 months after treatment to monitor treatment response 3, 5.
A fourfold decline in RPR titer (two dilutions) indicates successful treatment response, according to the Centers for Disease Control and Prevention 1, 3, 6.

The Centers for Disease Control and Prevention recommends that patients with penicillin allergy undergo desensitization followed by penicillin treatment, particularly if pregnant or if compliance with alternative regimens cannot be ensured 3, 5.

The Centers for Disease Control and Prevention advises against withholding treatment based on a low RPR titer of 1:1, as direct organism detection supersedes serologic titer interpretation 1, 2.
The Centers for Disease Control and Prevention recommends against using treponemal tests (FTA-ABS, TP-PA) to monitor treatment response, as these remain positive for life in most patients 1, 3, 6.